ABSTRACT
The use of recombinant bovine somatotropin (rbST) leads to an increase in variable amounts of milk production in buffalo, but there is a lack of information on the influence of rbST on their metabolism. This study looked at the effects of a single 500 mg dose of rbST on the lipid profile, liver and kidney function, and physical, chemical, and cellular constitution of milk in 14 buffalo over 14 days, from the 100th day of lactation, compared with 14 animals in a control group. From the first day after rbST, there was a rise in beta-hydroxybutyrate (ß-HBO), possibly due to higher dry matter intake or the biotransformation of NEFA into ß-HBO. The treatment did not influence blood glucose, non-esterified fatty acids (NEFAs), triglycerides, cholesterol, total protein, albumin, AST, GGT, bilirubin, urea, or creatinine levels. In 71.3% of the buffalo, there was a gradual increase in milk production, with the maximal response occurring in the first week followed by a gradual decrease, whilst in 21.4%, the increase in production occurred between 7 and 10 days. Only 7.1% of the animals did not respond. On the 3rd, 5th, 7th, and 10th days after treatment, an increase was found in daily milk production between the two groups equal to 1.04, 1.52, 1.42, and 1.06 L, respectively. In relative terms, this means an increase in milk production, respectively, of 15.1%, 21.0%, 19.8%, and 15.1%. The constitution of the milk showed no difference in the amounts of fat, lactose, total solids, or somatic cell count; however, on the third day after rbST administration, there was a decrease in protein. Notably, from the fifth day, the protein values showed no statistical difference. It can be concluded that the use of rbST in buffalo from the 100th day of lactation is metabolically safe since the treatment neither caused imbalances in fat metabolism nor overloaded the liver or renal function, and the changes in milk composition were transient and limited to a decrease in milk protein.
ABSTRACT
The aim of the present study is to evaluate the erythrogram and iron serum profiles of neonatal calves born spontaneously or born by elective cesarean section with or without dexamethasone induction. The research was performed on 38 newborn Nellore calves. Three groups of calves were assigned according to the type of birth: calves born by spontaneous vaginal calving (n = 10), calves born by elective cesarean section without inducing labor (n = 14), and calves born by elective cesarean section with labor induction with dexamethasone (n = 14). Blood samples to assess red blood cell count (RBC), hemoglobin, hematocrit, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), concentration of mean corpuscular hemoglobin (MCHC), serum iron (SFe), total capacity to bind iron to transferrin (TIBIC), and transferrin saturation index (TSI) were performed at calving (0, 3, 6, and 12 h of life) and on 1, 2, 3, 5, 7, 10, 15, and 30 days of life. Regardless of the experimental group (calves born spontaneously, or born by elective cesarean section with or without dexamethasone induction), in the first day of life there was a decrease in the number of red blood cells, hemoglobin rates, and values of the globular volume. In the period of the first 10 days of life, animals from spontaneous vaginal delivery quickly recovered values of erythrocytes, hemoglobin, and packed cell volume, whereas animals born by elective C-section (induced and uninduced) did not recover as quickly in their rates of hemoglobin and packed cell volume values. In calves born by elective C-section (induced and uninduced), it was observed in their period between 10 and 30 days of life that the MCV and MCH were reduced by passing the presenting microcytic hypochromic when compared with calves obtained by spontaneous vaginal delivery. In the period between 10 and 30 days of life, the levels of SFe and TSI in animals born by elective C-section (induced and uninduced) are significantly lower. The differences in the erythrogram values between Nellore calves born spontaneously and those by elective C-section with or without induction must be considered consequent to the process of neonatal adaptation to extrauterine life. Iron supplementation in the first month of life in calves from cesarean could be recommended to prevent anemia of this iron deficiency.
ABSTRACT
The aim of this study was to investigate the efficiency of low-level laser therapy (LLLT) to recovery testicular degeneration in rams. In the first study, rams were induced to testicular degeneration by scrotal insulation, and then, they were treated using LLLT at 28 J/cm(2) (INS28) or 56 J/cm(2) (INS56) energy densities. Sperm kinetics, morphology, and membranes integrity as well as proportion of lumen area in seminiferous tubule were assessed. In the second study, rams were submitted or not to scrotal insulation and treated or not by the best protocol of LLLT defined by experiment 1 (INS28). In this study were evaluated sperm kinetics, morphology, membranes integrity, ROS production, and DNA integrity. Testosterone serum concentration and proportion of lumen area in seminiferous tubule were also analyzed. Insulation was effective in promoting sperm injuries in both experiments. Biostimulatory effect was observed in experiment 1: INS28 presented smaller proportion of lumen area (P = 0.0001) and less degeneration degree (P = 0.0002). However, in experiment 2, there was no difference between the groups (P = 0.17). In addition, LLLT did not improve sperm quality, and there was a decreasing for total and progressive motility (P = 0.02) and integrity of sperm membranes (P = 0.01) in LLLT-treated groups. Moreover, testosterone concentration was not improved by LLLT (P = 0.37). Stimulation of aerobic phosphorylation by LLLT may have led to a deregulated increase in ROS leading to sperm damages. Thus, LLLT at energy of 28 J/cm(2) (808 nm of wavelength and 30 mW of power output) can induce sperm damages and increase the quantity of cells in seminiferous tubule in rams.
Subject(s)
Lasers, Semiconductor/therapeutic use , Low-Level Light Therapy , Testicular Diseases/radiotherapy , Animals , Male , Scrotum/radiation effects , Sheep, Domestic , Sperm Motility , Spermatozoa/physiology , Testis/radiation effects , Testosterone/bloodABSTRACT
Foram utilizadas 14 ovelhas Santa Inês, hígidas, no último mês de gestação que receberam duas aplicações de solução fisiológica (grupo controle-GC), ou 200 mg de acetato de α-tocoferol (vitamina E) (grupo tratado-GT), com intervalo de 14 dias, aos 21 e de 1 a 7 dias antes do parto, respectivamente para a primeira e segunda doses. As amostras de sangue foram coletadas previamente à primeira aplicação (M0), duas semanas após a primeira aplicação (M1), no parto (M2), uma semana (M3), duas semanas (M4) e quatro semanas após o parto (M5). Foram analisadas as concentrações de proteína total, albumina, globulina, ureia, creatinina, ácido úrico, colesterol, triglicérides, glicose, beta hidroxibutirato (BHB), ácidos graxos não esterificados (AGNEs); e as atividades séricas de creatinofosfoquinase (CK), aspartatoaminotransferase (AST) e gamaglutamiltransferase (GGT). Do metabolismo oxidativo foram determinadas as atividades da superóxido dismutase (SOD), glutationa peroxidase (GSH-Px), glutationa reduzida (GSH) e habilidade de redução férrica plasmática (HRFP). Não foram observadas diferenças entre GT e GC nas concentrações de proteína total, globulinas, CK, ácido úrico, glicose, triglicérides, BHB, AGNES, SOD, GSH-Px e GSH. Porém foram observadas maiores concentrações de albumina em M0 (P=0,039); ureia em M1 (P=0,018), M2 (P=0,005) e M3 (P=0,040); creatinina em M2 (P=0,030) e M3 (P=0,047); GGT em M1 (P= 0,01) e M2 (P=0,024), colesterol em M2 (P=0,041) e HRFP em M3 (P= 0,022) para GT em relação ao GC. A AST foi maior para o GC em relação ao GT em M2 (P=0,030). A aplicação de vitamina E (200 UI, via IM) aumentou a HRFP no pós-parto.(AU)
Fourteen healthy Santa Inês sheep, in the last month of pregnancy, were used. They were divided into two groups who received or two injections of saline solution (control group CG), or 200 mg of α-tocopherol acetate (vitamin E) (treated group TG) with range of 14 days at 21 and 1 to 7 days before delivery, respectively, to the first and second doses. Blood samples were collected prior to the first application (T0) two weeks after the first application (M1), at delivery (M2), one week (M3), two weeks (M4) and four weeks after birth (M5). We analyzed the concentrations of total protein, albumin, globulin, urea, creatinine, uric acid, cholesterol, triglycerides, glucose, beta-hydroxybutyrate (BHB), non esterified fatty acids (NEFA), and the activities of serum creatine kinase (CK), aspartate (AST) and gamma glutamyl transferase (GGT). Oxidative metabolism were valued by activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), reduced glutathione (GSH) and ferric reducing ability of plasma (FRAP). No differences were observed between TG and CG in the concentrations of total protein, globulin, CK, uric acid, glucose, triglycerides, BHB, NEFA, SOD, GSH-Px and GSH. However, higher concentrations were observed in M0 for albumin (P = 0.039); urea at M1 (P = 0.018), M2 (P = 0.005) and M3 (P = 0.040), creatinine at M2 (P = 0.030) and M3 (P = 0.047), GGT at M1 (P = 0.(AU)
Subject(s)
Animals , Peripartum Period/drug effects , Dietary Supplements , Parenteral Nutrition , Vitamin E/administration & dosage , SheepABSTRACT
Foram utilizadas 14 ovelhas Santa Inês, hígidas, no último mês de gestação que receberam duas aplicações de solução fisiológica (grupo controle-GC), ou 200 mg de acetato de α-tocoferol (vitamina E) (grupo tratado-GT), com intervalo de 14 dias, aos 21 e de 1 a 7 dias antes do parto, respectivamente para a primeira e segunda doses. As amostras de sangue foram coletadas previamente à primeira aplicação (M0), duas semanas após a primeira aplicação (M1), no parto (M2), uma semana (M3), duas semanas (M4) e quatro semanas após o parto (M5). Foram analisadas as concentrações de proteína total, albumina, globulina, ureia, creatinina, ácido úrico, colesterol, triglicérides, glicose, beta hidroxibutirato (BHB), ácidos graxos não esterificados (AGNEs); e as atividades séricas de creatinofosfoquinase (CK), aspartatoaminotransferase (AST) e gamaglutamiltransferase (GGT). Do metabolismo oxidativo foram determinadas as atividades da superóxido dismutase (SOD), glutationa peroxidase (GSH-Px), glutationa reduzida (GSH) e habilidade de redução férrica plasmática (HRFP). Não foram observadas diferenças entre GT e GC nas concentrações de proteína total, globulinas, CK, ácido úrico, glicose, triglicérides, BHB, AGNES, SOD, GSH-Px e GSH. Porém foram observadas maiores concentrações de albumina em M0 (P=0,039); ureia em M1 (P=0,018), M2 (P=0,005) e M3 (P=0,040); creatinina em M2 (P=0,030) e M3 (P=0,047); GGT em M1 (P= 0,01) e M2 (P=0,024), colesterol em M2 (P=0,041) e HRFP em M3 (P= 0,022) para GT em relação ao GC. A AST foi maior para o GC em relação ao GT em M2 (P=0,030). A aplicação de vitamina E (200 UI, via IM) aumentou a HRFP no pós-parto.
Fourteen healthy Santa Inês sheep, in the last month of pregnancy, were used. They were divided into two groups who received or two injections of saline solution (control group CG), or 200 mg of α-tocopherol acetate (vitamin E) (treated group TG) with range of 14 days at 21 and 1 to 7 days before delivery, respectively, to the first and second doses. Blood samples were collected prior to the first application (T0) two weeks after the first application (M1), at delivery (M2), one week (M3), two weeks (M4) and four weeks after birth (M5). We analyzed the concentrations of total protein, albumin, globulin, urea, creatinine, uric acid, cholesterol, triglycerides, glucose, beta-hydroxybutyrate (BHB), non esterified fatty acids (NEFA), and the activities of serum creatine kinase (CK), aspartate (AST) and gamma glutamyl transferase (GGT). Oxidative metabolism were valued by activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), reduced glutathione (GSH) and ferric reducing ability of plasma (FRAP). No differences were observed between TG and CG in the concentrations of total protein, globulin, CK, uric acid, glucose, triglycerides, BHB, NEFA, SOD, GSH-Px and GSH. However, higher concentrations were observed in M0 for albumin (P = 0.039); urea at M1 (P = 0.018), M2 (P = 0.005) and M3 (P = 0.040), creatinine at M2 (P = 0.030) and M3 (P = 0.047), GGT at M1 (P = 0.
Subject(s)
Animals , Parenteral Nutrition , Sheep , Peripartum Period/drug effects , Dietary Supplements , Vitamin E/administration & dosageABSTRACT
O transporte leva os animais ao estresse, que pode comprometer a saúde e bem estar destes, além de elevar a geração de substâncias reativas, aumentando a necessidade de antioxidantes. A idade também influencia o metabolismo, pois o envelhecimento causa modificações no organismo, levando a prejuízos funcionais. O objetivo deste estudo foi avaliar a influência do transporte rodoviário e da idade em cabras, tratadas ou não vitaminas A, D, e E. Foram utilizadas 20 cabras, da raça Boer, com cerca de 60 dias pós-parto, hígidas, manejo e dietas idênticos, de duas faixas etárias (de 1 até 4 anos de idade e entre 4 e 7 anos) e distribuídas em grupos de 10 animais. O transporte rodoviário teve duração de 4h. O exame físico e as coletas de sangue foram efetuados nos tempos T0 (-15d); T1 (-8d); T2 (-3d); T3 (0h); T4 (4h); T5 (5h); T6 (7h) e T7 (6d) do transporte. Em T1 e T2, 10 cabras receberam, via IM, 2mL de complexo com vitaminas A, D e E e 10 receberam solução fisiológica. Foram determinadas temperatura retal (TR); peso vivo (PV); escore de condição corporal (ECC); lactato L; ácidos graxos não esterificados (AGNEs); beta hidroxibutirato (BHB); ureia; creatinina; proteína total (PT); albumina; globulina; creatina fosfoquinase (cK); AST; GGT; glicose; eritrograma; concentrações eritrocitárias da superóxido dismutase (SOD) e o status antioxidante total (TAS). As variáveis PT, albumina, globulina, PV, ECC, AGNEs, AST, GGT, creatinina, ureia e eritrograma não se alteraram. O transporte diminuiu o BHB, não interferiu no TAS, mas em T4, as cabras mais jovens apresentaram menor TAS do que as com mais de 4 anos. A SOD não foi influenciada por transporte ou tratamento, sua concentração foi maior nas cabras jovens, e, nestas, quanto maior o ECC, menor a concentração de SOD. O estresse foi maior nas cabras de 1 a 4 anos.
Animal transportation can trigger stress. Stress could compromise health and livestock welfare, as well increases the generation of reactive substances and raise the need for antioxidants. Age also affect the metabolism, because aging causes organic modifications that lead to functional impairment. The aim of this study was to analyze the influence of short road transportation and age in goats, treated or not, with vitamins A, D and E. It were used 20 healthy female Boer goats, calved two months ago, with identical diet and management, divided in groups by age (1 to 4 years of age and 4 to 7 years) and distributed in groups of 10 animals. The transportation lasted 4 hours. Physical examination and blood collection were performed in times T0 (-15d); T1 (-8d); T2 (-3d); T3 (0h); T4 (4h); T5 (5h); T6 (7h) and T7 (6d) from transportation. In T1 and T2, 10 goats received, by intramuscular injection, 2 mL of complex with vitamins A, D and E and 10 animals received saline solution. It were collected the followings parameters: rectal temperature (RT); body weight (BW), body condition score (BCS); non esterified fatty acids (NEFA); β hydroxybutyrate (BHB); lactate L; urea; creatinine; total protein (TP); albumin; globulin; creatine phosphokinase (cK); AST; GGT; glucose; erithrogram; erythrocyte concentrations of superoxide dismutase (SOD) and total antioxidant status (TAS). There were no differences for the parameters TP, albumin, globulin, BW, BCS, NEFA, AST, GGT, creatinine, urea and erithrogram. The transportation decreased BHB, and it had shown no influence on TAS, but in T4, the younger goats had lower TAS than older ones. SOD was not affected by transport or treatment, but show greater concentration in young goats, and, only in this category, higher ECC leads to lower SOD. The stress was higher in 1 to 4 years goats.